Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
OMXC20 | OMXC20 | Apr 29, 2024 | 2 651.64 | -0.05 |
OrderYOYO | YOYO | Apr 29, 2024 | 8.60 | -6.52 |
Orphazyme | ORPHA | Apr 29, 2024 | 1 090.00 | 0.00 |
Pandora | PNDORA | Apr 29, 2024 | 1 086.00 | -1.27 |
Park Street A | PARKSTA | Apr 29, 2024 | 11.00 | -3.51 |
PARKEN Sport & Entertainment | PARKEN | Apr 29, 2024 | 117.00 | +1.74 |
Penneo | PENNEO | Apr 29, 2024 | 7.38 | +1.37 |
Per Aarsleff Holding B | PAALB | Apr 29, 2024 | 327.00 | +1.71 |
Pharma Equity Group | PEG | Apr 29, 2024 | 0.24 | -4.38 |
Prime Office | PRIMOF | Apr 29, 2024 | 185.00 | +3.93 |
Q-Interline | QINTER | Apr 29, 2024 | 7.50 | 0.00 |
Relesys | RELE | Apr 29, 2024 | 6.40 | 0.00 |
Rias B | RIASB | Apr 29, 2024 | 655.00 | -2.96 |
Ringkjøbing Landbobank | RILBA | Apr 29, 2024 | 1 184.00 | +1.72 |
Risk Intelligence | RISK | Apr 29, 2024 | 1.14 | -3.40 |
RISMA Systems | RISMA | Apr 29, 2024 | 8.95 | -1.11 |
Roblon B | RBLNB | Apr 29, 2024 | 81.00 | -0.61 |
Rockwool AS, ser A | ROCKA | Apr 29, 2024 | 2 310.00 | -1.28 |
Rockwool AS, ser B | ROCKB | Apr 29, 2024 | 2 304.00 | -1.37 |
Rovsing | ROV | Apr 29, 2024 | 36.20 | +0.56 |
Royal UNIBREW | RBREW | Apr 29, 2024 | 539.00 | +1.13 |
RTX | RTX | Apr 29, 2024 | 94.80 | -0.42 |
SAS | SASDKK | Apr 29, 2024 | 0.02 | -1.91 |
Scandinavian Brake Systems | SBS | Apr 29, 2024 | 11.65 | -0.85 |
Scandinavian Investment Group | SIG | Apr 29, 2024 | 3.18 | 0.00 |
Scandinavian Medical Solutions | SMSMED | Apr 29, 2024 | 7.60 | +1.33 |
Scandinavian Tobacco Group | STG | Apr 29, 2024 | 113.40 | +0.35 |
Scape TechnologieS | SCAPE | Apr 29, 2024 | 0.66 | -1.19 |
Schouw & Co. | SCHO | Apr 29, 2024 | 529.00 | +0.76 |
Seluxit | SLXIT | Apr 29, 2024 | 3.26 | -6.86 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.